BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21989858)

  • 1. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
    Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
    Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study.
    Miyagawa Y; Tsujimura A; Matsumiya K; Takao T; Tohda A; Koga M; Takeyama M; Fujioka H; Takada S; Koide T; Okuyama A
    J Urol; 2005 Jun; 173(6):2072-5. PubMed ID: 15879837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
    Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
    Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
    Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
    Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
    Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
    Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of testicular DNA synthesis in vitro by hCG and hMG treatments in men with hypogonadotropic hypogonadism.
    Okuyama A; Nonomura N; Koh E; Kondoh N; Nakamura M; Namiki M; Kiyohara H; Nishimune Y; Matsumoto K; Matsuda M
    Arch Androl; 1989; 23(1):39-43. PubMed ID: 2506842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.